Disease Kinetics Measured By Circulating Tumor DNA Correlates with Treatment Response after Tafasitamab in Combination with R-CHOP with or without Lenalidomide in First Line Treatment of DLBCL
Title: | Disease Kinetics Measured By Circulating Tumor DNA Correlates with Treatment Response after Tafasitamab in Combination with R-CHOP with or without Lenalidomide in First Line Treatment of DLBCL |
---|---|
Authors: | Khouja, Mouhamad, Schilhabel, Anke, Kotrova, Michaela, Brüggemann, Monika, Kuffer, Christian, Blair, Derek, Darzentas, Nikos, Pott, Christiane |
Source: | In Blood 23 November 2021 138 Supplement 1:3498-3498 |
Database: | ScienceDirect |
ISSN: | 00064971 |
---|---|
DOI: | 10.1182/blood-2021-153176 |
Published in: | Blood |
Language: | English |